Subtype
Pituitary Neuroendocrine Tumor of PIT1-Lineage
CI-CAN-00006427Explore in graph →
Non-malignant2 active trials
- NCIt
- C187086
Loading cancer entity…
Subtype
CI-CAN-00006427Explore in graph →
Clinical trials
22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03457389 | Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma | unknown | N/A | 68 | Seoul National University HospitalOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT03717454 | Dopamine D2 Receptors(D2R) Imaging in Prolactinomas | unknown | N/A | 50 | Zhebao WuOTHER | 0 | Nov 20, 2018 | clinicaltrials |
| NCT03400865 |
| Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas |
| unknown |
| N/A |
| 30 |
| Zhebao WuOTHER |
| 1 |
| Oct 16, 2018 |
| clinicaltrials |
| NCT03353025 | Study on Therapy of Non-invasive Prolactinoma(TNAPA) | unknown | N/A | 394 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Nov 24, 2017 | clinicaltrials |
| NCT01775332 | Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools | unknown | N/A | 60 | Unity Health TorontoOTHER | 1 | Jul 31, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Mar 18, 2020source: clinicaltrials